Article info
Editors’ commentary
Highlights from this issue
- Correspondence to Dr Geraint N Fuller, Gloucester Royal Hospital, Gloucester, UK; geraint.fuller{at}nhs.net
Citation
Highlights from this issue
Publication history
- Accepted June 10, 2022
- First published July 18, 2022.
Online issue publication
July 18, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Understanding the pathophysiology of idiopathic intracranial hypertension (IIH): a review of recent developments
- Idiopathic intracranial hypertension: consensus guidelines on management
- Diagnosis and management of benign intracranial hypertension
- A practical approach to, diagnosis, assessment and management of idiopathic intracranial hypertension
- Characterising the patient experience of diagnostic lumbar puncture in idiopathic intracranial hypertension: a cross-sectional online survey
- Serum leptin level in women with idiopathic intracranial hypertension
- Factor V Leiden mutation in association with idiopathic intracranial hypertension
- 10 IDIOPATHIC INTRACRANIAL HYPERTENSION, POLYCYSTIC OVARY SYNDROME, AND THROMBOPHILIA
- Optical coherence tomography imaging of the optic nerve head pre optic and post optic nerve sheath fenestration
- Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum